Quarterly Result: Vivimed Labs Ltd
Bhagyashree Vivarekar / 15 Nov 2016
Vivimed Labs Ltd., is currently trading at Rs. 87.8, down by 5.95 points or 6.35% from its earlier closing of Rs. 93.75 on the BSE.The company's net profit has surged by 12.44% yoy to Rs 26.85 cr.
Technical View:
Vivimed Labs Ltd., is currently trading at Rs. 87.8, down by 5.95 points or 6.35% from its earlier closing of Rs. 93.75 on the BSE.
The scrip has touched a high and low of Rs. 93.7 and Rs. 85.25 respectively, after opening at 93.7. Altogether 374298(NSE+BSE) shares have been traded on the counter; and the stock is currently trading above its 50 DMA.
Standalone Results Q2FY17:
Bloomberg estimates were higher than Vivimed Labs Ltd’s Q2FY17 standalone numbers. Revenue for the period has come in 21.2% lesser than the estimate of Rs 380 cr. Reported net profit for the period has come in 5.8% lesser than the estimate of Rs 29 cr.
The quarter's revenue has declined by 12.4% yoy to Rs 299.29 cr. Speciality chemical segment has registered 24% yoy erosion to Rs 45 cr.
Vivimed's EBITDA has dropped 3.1% yoy to Rs 61.22 cr while EBITDA margins have improved 196 bps yoy to 20.5%. Employee cost has surged 10% yoy to Rs 41.41 cr.
The company's net profit has surged by 12.44% yoy to Rs 26.85 cr. Finance cost has eroded 21% yoy to Rs 14.94 cr.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.